Thank you for submitting your manuscript to the EMBO Journal. Your study has now been seen by four referees and their comments to the authors are provided below. As you can see from these comments and as is also evident from their overall evaluations, the referees find the analysis very interesting and appropriate for the journal. However, they also raise a number of specific concerns that have to be resolved before further consideration here. I would therefore like to ask you to submit a suitably revised manuscript, should you be able to address the raised concerns in full. I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
The manuscript by Gummesson et al presents straightforward, yet very elegant and convincing, set of data aimed to test alternative models for regulation of gene expression in bacteria in response to nutrient availability. In the two currently popular models, an increase in free pool of RNAP sigma70 holoenzyme is predicted to have opposite effects on the transcription from difficult-to-saturate (hyper-active) promoters that drive expression the components of the translational machinery (e.g., rrn promoters) and readily saturatable promoters (e.g., those controlling stress response). These models are frequently invoked to explain the mechanism of action of the alarmone ppGpp. Gummesson et al artificially increase the pool of core/sigma70 complex by overexpressing (2-3 fold) the major core and sigma subunits from plasmids and determine the effect thereof on gene expression, pool of free enzyme, protein damage, motility, etc. In essence, their data argue that overexpression of the sigma70 holoenzyme mimics the effects of reduced levels of ppGpp and diverts the cell resources to rapid growth at the expense of maintenance mechanisms. Conversely, these data suggest that modulation of holoenzyme levels in the cell constitutes a global mechanism by which ppGpp acts to adjust gene expression in response to environmental cues. By extension, it also means that the holoenzyme expression and/or levels are under a tight control, likely by other factors as well. I am quite convinced by the data, and have only minor comments. 1. The competing models are set up quite well in the introduction; however, this description may be too wordy. I think that a schematic representation of the models (in Figure 1 ) with their (opposite) predictions would allow the authors to shorten the description and, more importantly, make the contrast more obvious. 2. The pool of free RNA polymerase may consist of both free core enzyme and free holoenzyme; there are still arguments in the field whether free core exists (if yes, likely bound to the DNA nonspecifically). Even though the main argument of this work concerns the initiation-competent holoenzyme, it would be interesting to know if the authors expressed both components separately. This point is particularly obvious in the discussion where the authors consider various ways of RNA polymerase sequestration (such as a statement that Esigma70 is sequestered in the elongation phase). While it is true that sigma was found associated with the elongation complexes, most of these observations are only true for the early elongation, or for the in vitro analysis. At later steps, NusG likely sterically blocks sigma binding site. In this light, it is interesting to know whether sigma retention under stress conditions reported by the Nudler lab could be due to diminished levels of NusG. 3. Figure 7 a) in the inset, the dashes for the 1/0.1 curve do not really show well. Just increase the inset, or make this trace thick and gray, for example b) I would re-phrase the last sentence to something like "...remain unaltered, but their relative expression actually decreases at higher concentration of Esigma70 relative to the total transcription in the cell.
Referee #2 (Remarks to the Author):
This is a very interesting paper that provides evidence that increase in RNA polymerase availability may be the main factor that regulates growth control in E. coli. Given the importance of the topic, conflicting views on the subject, and the fact that despite the numerous attempts definitive conclusions have been elusive, I would like to see several additional experiments/controls before I can advise on the suitability of this paper for publication.
The approach that the authors use, increasing the amount of RNAP in the cell by cooverexpressing its subunits, suffers from a potential problem since not all subunits are overproduced equally (for example alpha, which is present in two copies in the enzyme, appears to be expressed at lower levels than beta', and beta', meaning that the actual levels of RNAP increase are less, perhaps much less, than the authors think they are). The authors need to at least comment on this or, better, purify RNAP from their cells and get estimates of the enzyme yields. In addition, it is not clear that sigma that they overproduce does in fact enter the holoenzyme. I would like to see the consequences of RNAP core subunits overproduction to be tested as a control for every experiment reported in the paper. When presenting data on RNAP overproduction effects on individual genes, the authors use as a control data with the beta-beta' plasmid. Data with the alpha-sigma plasmid shall be included. Sigma subunit antibody shall be included in IP experiment; cells overproducing RNAP core only shall also be used in this experiment.
Referee #3 (Remarks to the Author):
The manuscript by Gummesson et al., entitled 'Increased RNA Polymerase availability directs resources towards growth at the expense of maintenance' addresses a very important question. The authors are interested in the passive control of gene expression when E. coli cells encounter growth limitation conditions; they try to differentiate between Saturation and Affinity models. By employing a simple and yet ingenious method of increasing RNAP levels by only about two folds, the authors perform a wide array of experiments where they demonstrate that elevated RNAP levels mimic the relaxed response. The authors then conclude that the saturation model is more fit to describe the passive control, with the caveat that ppGpp is the factor influencing free sigma70-holoenzyme levels. I found this report to be of great interest and believe it to be important both in the field as well as to the general audience. Nevertheless, several issues arise that should be addressed by the authors. There are two major concerns. One is that the observed effects of elevating Esigma70 on promoters controlled by ppGpp (both negatively and positively) could be explained by simply diluting out ppGpp by increased RNA polymerase concentration. Repeating some of the experiments in ppGpp0 background should amend for that. The second is that the authors conclude (and heavily rely on this later on) that in ppGpp0 strains free Esigma70 levels are elevated when compared to wt, while sigma70 levels were actually not assessed (only RpoC and RpoA levels were measured). I strongly encourage the authors to address these issues, as the work presented is valuable to the field.
Specific comments:
1. Fig.1 .B. presents a Western blot where the levels of overproduced RNAP (Es70) subunits were measured; the conclusion is that RNAP is elevated by 2fold in comparison to wt. The samples were taken in the exponential phase, however many experiments that follow were performed in the stationary phase. Does RNAP continue to be elevated by 2-fold in the stationary phase as well? 2. Fig.1 .D. demonstrates that elevating RNAP by IPTG induction increases rrnB P1 activity by about 1.5-2 folds. The authors conclude this is in accordance with the saturation model. However, these results could be also explained by the fact that elevated RNAP dilutes out ppGpp, thus lesser direct repression of rrnB P1. This could be resolved if the experiment was repeated in a ppGpp0 background.
3. Fig. 1E and pg.8 top. The authors "...conclude that overproduction of Esigma70 is not causing elevated expression from rrnBP1 by influencing the levels of ppGpp or DksA". This conclusion is based on results obtained with dksA-strain, where upon Es70 overproduction the activation fold of rrnBP1 activity is similar to that in dksA+ strain. To make such a statement, DksA levels should be measured. Thus, I think it would be more appropriate to say that 'activation of rrnB P1 by elevated Es70 seems to be independent of DksA', rather than 'DksA levels are unaffected'. 4. Fig.1F . It is puzzling that upon Es70 overproduction less ppGpp is produced right upon entrance into stationary phase than in the wt. One would expect the opposite, since more RNAP would mean more mRNA production, thus increase in overall translation and on average more frequent ribosomal pausing that in turn would activate RelA and lead to increased ppGpp production. Could the authors comment on this? 5. Fig.2 . A, B. Again, lowered expression of the uspA, uspD, livJ and thrABC promoters upon Es70 induction could be explained by diluting out ppGpp. Panel E seems to confirm this, as in the stationary phase (when ppGpp levels increase in the wt) expression of both uspA constructs seems to be increased. I assume here, results in 2E were obtained in the presence of IPTG with plasmids overproducing Es70 (not clear). If this assumption is incorrect, it would be desirable to repeat experiment from panel 2B with ppGpp0 strains (for at least one of the promoters).
6. Fig2.D-were the samples taken in exponential or stationary phase? Also, please address in the Discussion section or elsewhere, why there is a seeming discrepancy between occupancy and promoter activity for the rrnB P1 promoter (5-fold increased occupancy vs.
at most 2-fold increased activity upon Es70 overproduction). 7. Fig. 3 . Would elevating Es70 levels in ppGpp0 also decrease motility or have no effect? 8. Fig5. As mentioned above, here sigma70 levels were not measured thus it cannot be concluded that in ppGpp0 strains free Es70 levels are elevated. This conclusion can be made only about core RNAP. It would be of great interest and importance to perform such estimates with sigma 70 antibodies. It would also be interesting, but not really crucial, to assess levels of other sigma factors bound with core, if such antibodies were readily available.
9. Fig. 6 . The authors should be praised for using the spoT201 allele that elevates ppGpp levels by only 2 fold. This should be fitting as Es70 levels, when induced, are also increased by about 2 folds. On the other hand, one cannot help but wonder-what would happen if ppGpp levels were increased even more? Would this in turn abolish the effect of overproducing Es70?
Referee #4 (Remarks to the Author):
The manuscript by Gummesson et al. addresses an important problem of global gene regulation in bacteria, that of the mechanism of the stringent response and growth rate control. The authors approach this question by reducing competing explanations of altered patterns of transcription behind this phenomenon to two divergent models (Saturation and Affinity). They then identified cellular conditions, where results of perturbing concentration of free RNAP holoenzyme would be different depending on which of the two models were correct. Having overexpressed RNAP subunits alpha, beta, beta', and sigma (components of RNAP holoenzyme) they used a combination of methods to score the effects of elevated holoenzyme concentration on gene expression in the cell (e.g. beta-gal of reporter promoter constructions, ChIP assay for promoter occupancy) as well as its physiological effects (cell motility, protein carbonylation).
The bulk of the data reported in the manuscript is consistent with the Saturation model in a way that overproduction of free holoenzyme appears to mimic relaxed phenotype both transcriptionally and physiologically. Moreover, such overproduction suppressed the effects of elevated ppGpp concentration, further stressing the direct role the elevated (or reduced) concentration of free holoenzyme plays in the stringent response.There are, however, some methodological caveats in this work that preclude acceptance of its conclusions as submitted. One of the most serious of them is the lack of proper controls in establishing the primary assumption, namely that the overproduction of holoenzyme components resulted in concomitant increase in free holoenzyme concentration. The Western blot (Fig. 1B) reflects total levels of expressed subunits, not of the assembled holoenzyme. This blot does not prove the increase of the free holoenzyme concentration, nor even that the total concentration of the holoenzyme increased. A more rigorous proof of this assumption (upon which rest majority of interpretations in this manuscript) would be to compare immunoaffinity purified holoenzymes (necessary resins are available from Neoclone, the supplier of antibodies used in ChIP experiments).
Another caveat of this approach is the exclusion of omega subunit from the set of overexpressed holoenzyme components. As noted in the manuscript itself, absence of omega from the RNAP was reported to reduce enzyme's sensitivity to ppGpp. General discussion of DksA or omega deletion/overexpression experiments (Fig. 2C) is no substitute for direct demonstration of omega presence or absence in the overexpressed holoenzyme. It may well be that due to limited overexpression of other subunits, the assembled holoenzyme will still be saturated by omega to the same degree as it is in uninduced conditions, but direct determination of the concentration and stoichiometry of the complex designated as Esigma70 is of essence for interpretation of the data in this manuscript.
A third methodological problem this reviewer sees in determination of the free Esigma70 (=holoenzyme) concentration using minicell approach. This approach is based on largely unproven assumption that the concentration of a holoenzyme in the minicell is indicative of the same in normal cell. The authors separate crude extract from the minicells using gel filtration and quantify alpha and beta' subunits in different fractions. There is no explanation for the lack of assay for sigma70 in these fractions, without which designating any of the complexes Esigma70 is presumptuous. Moreover, there is no total congruity even between alpha and beta' signals, which argues for presence of various subassemblies at least in the minicell. Once again, in order to claim quantification of the Esigma70 complex, presence of all requisite subunits in requisite stoichiometries has to be demonstrated directly.
Another concern is that protein overproduction is often causes stress to the cell. The authors have to be sure that expression of RNAP subunits per se does not affect global regulation. Expression of some large protein to the same or greater extent may serve as a negative control in this case.
Provided that the lacking controls can be easily remedied and do not lead to a major shift in starting assumptions, the conclusions of this manuscript represent an important step in our understanding of stringent and growth rate control mechanisms. Referee #1: Remark 1: The competing models are set up quite well in the introduction; however, this description may be too wordy. I think that a schematic representation of the models (in Figure 1) with their (opposite) predictions would allow the authors to shorten the description and, more importantly, make the contrast more obvious.
Response 1:1 We have added a figure that describes predictions from the competing models on how expression from different promoter types respond to overproduction of E 70 (Fig. 1) . We have also shortened the description in the introduction according to the refereesí suggestion.
Remark 2: The pool of free RNA polymerase may consist of both free core enzyme and free holoenzyme; there are still arguments in the field whether free core exists (if yes, likely bound to the DNA nonspecifically). Even though the main argument of this work concerns the initiationcompetent holoenzyme, it would be interesting to know if the authors expressed both components separately. This point is particularly obvious in the discussion where the authors consider various ways of RNA polymerase sequestration (such as a statement that Esigma70 is sequestered in the elongation phase). While it is true that sigma was found associated with the elongation complexes, most of these observations are only true for the early elongation, or for the in vitro analysis. At later steps, NusG likely sterically blocks sigma binding site. In this light, it is interesting to know whether sigma retention under stress conditions reported by the Nudler lab could be due to diminished levels of NusG. Response 1:2 We agree with the referee that the mechanisms leading to decreased E 70 levels under stress conditions are of outmost interest, and this is the next step in understanding the global regulation of gene expression. However, as the referee also mentioned, it is outside the scope of this study; instead we focus on demonstrating the relationship between (i) the E 70 levels and the activity of certain promoters and (ii) the levels of ppGpp and E 70. In addition, overproducing core subunits alone exhibit experimental problems since we and others have seen that it will bring up expression from chromosomal rpoD (encoding 70) (Dykxhoorn et al. 1996) . Thus, it is not possible to "only" overproduce core without simultaneously increasing the holoenzyme levels. Instead, overproduction of only + 70 or only + ' was used as controls. (see also response 2:2)
Remark 3: Figure 7 a) in the inset, the dashes for the 1/0.1 curve do not really show well.Just increase the inset, or make this trace thick and gray, for example b) I would re-phrase the last sentence to something like "...remain unaltered, but their relative expression actually decreases at higher concentration of Esigma70 relative to the total transcription in the cell. Response 1:3 The revised manuscript has been updated in line with theses suggestions to enhance readability.
Referee #2:
Remark 1: The approach that the authors use, increasing the amount of RNAP in the cell by cooverexpressing its subunits, suffers from a potential problem since not all subunits are overproduced equally (for example alpha, which is present in two copies in the enzyme, appears to be expressed at lower levels than beta', and beta', meaning that the actual levels of RNAP increase are less, perhaps much less, than the authors think they are). The authors need to at least comment on this or, better, purify RNAP from their cells and get estimates of the enzyme yields. In addition, it is not clear that sigma that they overproduce does in fact enter the holoenzyme. Response 2:1 Achieving a non-biased level of the different RNAP subunits is, as noted by the referee, an intrinsic problem when over-expressing them. However, we do measure the overproduction levels of the separate subunits relative to their respective wild-type levels using Western blot (Fig. 2B) . It is true that the alpha subunit results in the lowest levels of overproduction levels; however the 2-fold overproduction shown in Fig. 2B is related to the wild-type levels, which means that the stoichiometry is accounted for automatically. In addition, we have added a new experiment in the manuscript were we directly address the question of how much the holoenzyme is overproduced. We did this by affinity purification of ' from cells over-expressing E 70 (and from cells over-expressing + 70 alone) and examined the 70 co-purification. This experiment confirmed a 2 fold higher E 70 level when overproducing all the subunits (but no increased levels in the control experiment) and the result has been added in figure 2C .
Remark 2: I would like to see the consequences of RNAP core subunits overproduction to be tested as a control for every experiment reported in the paper. Response 2:2 Overproducing core subunits alone exhibit experimental problems since we and others have seen that it will bring up expression from chromosomal rpoD (encoding 70) (Dykxhoorn et al. 1996) . Thus, it is not possible to "only" overproduce core without simultaneously increasing the holoenzyme levels. Instead, overproduction of only + 70 or only + ' was used as controls. The results of these additional controls have been added in the text and in figures 2E and 3B.
Remark 3: When presenting data on RNAP overproduction effects on individual genes, the authors use as a control data with the beta-beta' plasmid. Data with the alpha-sigma plasmid shall be included. Referee #3: Remark 1: One is that the observed effects of elevating Esigma70 on promoters controlled by ppGpp (both negatively and positively) could be explained by simply diluting out ppGpp by increased RNA polymerase concentration. Repeating some of the experiments in ppGpp0 background should amend for that. Response 3:1 This is an intriguing issue that has to do with the mechanism of action of ppGpp, and it also leads to a "chicken and egg" problem with the increased levels of RNAP. Thus, we do not expect that over-expression of E 70 in a ppGpp0 background will increase expression much, because a ppGpp0 strain already has increased levels of RNAP (Fig. 5) and a relaxed phenotype. However, we did the experiment and found that overexpression caused further, but smaller, increase in rrn expression; this has been added in the manuscript (Fig. 2E ).
Remark 2: The second is that the authors conclude (and heavily rely on this later on) that in ppGpp0 strains free Esigma70 levels are elevated when compared to wt, while sigma70 levels were actually not assessed (only RpoC and RpoA levels were measured). Response 3:2 We realize the importance of this data and performed the experiment and found that 70 levels were approximately 2-fold higher in ppGpp0 cells compared to the wild type cells. This has now been included in figure 6B.
Remark 3: Fig.1 .B. presents a Western blot where the levels of overproduced RNAP (Es70) subunits were measured; the conclusion is that RNAP is elevated by 2fold in comparison to wt. The samples were taken in the exponential phase, however many experiments that follow were performed in the stationary phase. Does RNAP continue to be elevated by 2-fold in the stationary phase as well? Response 3:3 Yes, this info has been added in the text.
Remark 4: Fig.1 .D. demonstrates that elevating RNAP by IPTG induction increases rrnB P1 activity by about 1.5-2 folds. The authors conclude this is in accordance with the saturation model. However, these results could be also explained by the fact that elevated RNAP dilutes out ppGpp, thus lesser direct repression of rrnB P1. This could be resolved if the experiment was repeated in a ppGpp0 background. Response 3:4 Yes, now include -see response 3:1
Remark 5: Fig. 1E and pg.8 top. The authors "...conclude that overproduction of Esigma70 is not causing elevated expression from rrnBP1 by influencing the levels of ppGpp or DksA". This conclusion is based on results obtained with dksA-strain, where upon Es70 overproduction the activation fold of rrnBP1 activity is similar to that in dksA+ strain. To make such a statement, DksA levels should be measured. Thus, I think it would be more appropriate to say that 'activation of rrnB P1 by elevated Es70 seems to be independent of DksA', rather than 'DksA levels are unaffected'. Response 3:5 We agree with the reviewer and the text has been changed accordingly.
Remark 6: Fig.1F . It is puzzling that upon Es70 overproduction less ppGpp is produced right upon entrance into stationary phase than in the wt. One would expect the opposite, since more RNAP would mean more mRNA production, thus increase in overall translation and on average more frequent ribosomal pausing that in turn would activate RelA and lead to increased ppGpp production. Could the authors comment on this? Response 3:6 First, it should be noted that the growth curve in the presence of IPTG reaches stationary phase a little bit later than without IPTG. Thus, it is easy to over-estimate the difference between the ppGpp expression curves. On the other hand, as noted by the referee, it is obvious from the ppGpp measurements that the level of RNAP over-expression that we are studying does not result in a stringent response, in contrast and in line with the ppGpp curve, we see relaxed phenotypes when over-expressing RNAP.
Remark 7: Fig.2 . A, B. Again, lowered expression of the uspA, uspD, livJ and thrABC promoters upon Es70 induction could be explained by diluting out ppGpp. Panel E seems to confirm this, as in the stationary phase (when ppGpp levels increase in the wt) expression of both uspA constructs seems to be increased. I assume here, results in 2E were obtained in the presence of IPTG with plasmids overproducing Es70 (not clear). If this assumption is incorrect, it would be desirable to repeat experiment from panel 2B with ppGpp0 strains (for at least one of the promoters). Response 3:7 Fig. 2E /F (now Fig. 3E /F) might not have been explained properly, and both the text and the figure legends are now updated for clarity. Panel E/F shows both PuspA promoter and a hybrid uspA promoter fused to an UP-element and their dependency of ppGpp when the cells enter stationary phase. These experiments are not a part of the overproduction experiments. Regarding the suggested experiment using a ppGpp0 strain, a further attenuation of expression in the uspA promoter is hard to assess since this promoter has very low activity without ppGpp. Nevertheless, we did the experiment and could not detect any changes in expression.
Remark 8: Fig2.D-were the samples taken in exponential or stationary phase? Response 3:8 The samples are taken at OD (420nm) 0.7 and this information has been added in materials and methods.
Remark 9: Also, please address in the Discussion section or elsewhere, why there is a seeming discrepancy between occupancy and promoter activity for the rrnBP1 promoter (5-fold increased occupancy vs. at most 2-fold increased activity upon Es70 overproduction). Response 3:9 It is likely that the -gal construct we use to determine the expression activity underestimate the promoter strength at high expression levels due to the missing anti-terminator sequence in the construct. It has been shown that the anti-terminator sequence results in higher elongation rate and therefore it is possible that queue of RNAP is limiting the initiation on the -gal construct rather than the intrinsic initiation capacity of the promoter. This issue is added to the discussion of the revised manuscript.
Remark 10: Fig. 3 . Would elevating Es70 levels in ppGpp0 also decrease motility or have no effect? Response 3:10 This will have no effect since a ppGpp0 have no flagella and is not motile (see Magnusson et al 2007) .
Remark 11: Fig5. As mentioned above, here sigma70 levels were not measured thus it cannot be concluded that in ppGpp0 strains free Es70 levels are elevated. This conclusion can be made only about core RNAP. It would be of great interest and importance to perform such estimates with sigma 70 antibodies. It would also be interesting, but not really crucial, to assess levels of other sigma factors bound with core, if such antibodies were readily available. Response 3:11 We agree with the reviewer and have accordingly estimated the 70 levels, which are now added to Fig. 6 . However, since this manuscript concerns the levels of E 70 we leave the alternative sigma factors for future studies.
Remark 12: Fig. 6 . The authors should be praised for using the spoT201 allele that elevates ppGpp levels by only 2 fold. This should be fitting as Es70 levels, when induced, are also increased by about 2 folds. On the other hand, one cannot help but wonder-what would happen if ppGpp levels were increased even more? Would this in turn abolish the effect of overproducing Es70? Response 3:12 This is an interesting question that we also hope to clarify in the future. Referee #4: Remark 1: There are, however, some methodological caveats in this work that preclude acceptance of its conclusions as submitted. One of the most serious of them is the lack of proper controls in establishing the primary assumption, namely that the overproduction of holoenzyme components resulted in concomitant increase in free holoenzyme concentration. The Western blot (Fig. 1B) reflects total levels of expressed subunits, not of the assembled holoenzyme. This blot does not prove the increase of the free holoenzyme concentration, nor even that the total concentration of the holoenzyme increased. A more rigorous proof of this assumption (upon which rest majority of interpretations in this manuscript) would be to compare immunoaffinity purified holoenzymes (necessary resins are available from Neoclone, the supplier of antibodies used in ChIP experiments).
Response 4:1 This is a necessary and important control (also pointed out by referee #2, see response 2:1) and we have added this experiment in the manuscript. In the experiment we address the question how much holoenzyme is produced by affinity purification of ' from cells over-expressing E 70 and examined the 70 co-purification. This confirmed that we have 2 fold higher levels of E 70 complexes and the result is added to figure 2C . In addition we demonstrate that holoenzyme levels do not increase when and 70 alone was overproduced (Fig. 2C ).
Remark 2: Another caveat of this approach is the exclusion of omega subunit from the set of overexpressed holoenzyme components. As noted in the manuscript itself, absence of omega from the RNAP was reported to reduce enzyme's sensitivity to ppGpp. General discussion of DksA or omega deletion/overexpression experiments (Fig. 2C ) is no substitute for direct demonstration of omega presence or absence in the overexpressed holoenzyme. It may well be that due to limited overexpression of other subunits, the assembled holoenzyme will still be saturated by omega to the same degree as it is in uninduced conditions, but direct determination of the concentration and stoichiometry of the complex designated as Esigma70 is of essence for interpretation of the data in this manuscript. Response 4:2 We have elucidated the role of by measuring promoter activity from rrnBP1-41-+50-lacZ and PuspA-lacZ upon E 70 overproduction in cells lacking and found that the absence of this subunit did not alter the effect of E 70 overproduction. Thus, even if overproduction of E 70 would result in a lower fraction of holoenzymes containing , this can not explain the results since overproduction of E 70 in cells totally lacking display the same response as wild type cells. The data is now included in figure 2E and 3B.
Remark 3: A third methodological problem this reviewer sees in determination of the free Esigma70 (=holoenzyme) concentration using minicell approach. This approach is based on largely unproven assumption that the concentration of a holoenzyme in the minicell is indicative of the same in normal cell. The authors separate crude extract from the minicells using gel filtration and quantify alpha and beta' subunits in different fractions. There is no explanation for the lack of assay for sigma70 in these fractions, without which designating any of the complexes Esigma70 is presumptuous. Moreover, there is no total congruity even between alpha and beta' signals, which argues for presence of various subassemblies at least in the minicell.
